Related Experiment Video
Updated: May 14, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Clearance and bioavailability study through arterio-venous drug concentrations relationship
Pietro Fagiolino1, Marta Vázquez, Rosa Eiraldi
1Department of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, Uruguay. pfagioli@fq.edu.uy
Summary
Monitoring the ratio of arterial to venous drug concentrations can efficiently track pharmacokinetic parameters like bioavailability and clearance. This method allows for timely detection of changes in drug absorption or disposition without prolonged observation.
Area of Science:
- Pharmacokinetics
- Drug Monitoring
- Systems Biology
Background:
- Plasma drug concentrations are routinely monitored to understand pharmacokinetic parameters and drug effects.
- Arterial and venous drug concentrations differ based on whether drug input or elimination predominates.
Purpose of the Study:
- To evaluate the utility of the arterial-venous plasma drug concentration ratio for monitoring pharmacokinetic parameters.
- To assess the efficiency of this ratio in detecting changes in drug absorption and disposition.
Main Methods:
- Analyzing the arterial-venous plasma drug concentration ratio across different phases of drug administration and elimination.
- Utilizing non-eliminating organs to observe the drug concentration dynamics.
Main Results:
- The arterial-venous drug concentration difference reflects current drug bioavailability and clearance.
- The vein/artery plasma drug concentration ratio at a non-eliminating organ can monitor these parameters over time.
Conclusions:
- Monitoring the arterial-venous drug concentration ratio offers an efficient method for assessing pharmacokinetic parameters.
- This approach enables early detection of modifications in drug absorption or disposition, irrespective of the duration of the change.
Related Concept Videos
01:06Drug Elimination: The Concept of Clearance
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:30Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
01:13Bioavailability: Overview
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
01:17Bioavailability: Overview
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
01:17Clearance Models: Noncompartmental Models
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...